Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Revogenex
A review of biopharma start-up dealmaking and financing activity from October through December 2018, based on data from Strategic Transactions.
Immunotherapy firms Edge and PDS announce planned merger, while Telix advances its prostate cancer strategy by acquiring ANMI. Kyowa Hakko Kirin is signed up to distribute GlaxoSmithKline's Phase III CKD-associated anemia product daprodustat in Japan.
- Drug Delivery
- Other Names / Subsidiaries
- Revogenex Ireland Ltd.